FROM GUIDELINES TO IMPLEMENTATION:
A WORLD WITHOUT DIABETES STARTS HERE

The 4th World Congress on Interventional Therapies for Type 2 Diabetes is a comprehensive, multidisciplinary forum where clinicians, scientists, and policy makers will conduct a critical review and discussion of the latest research findings on metabolic/bariatric surgery and novel interventional therapies for type 2 diabetes. The first three editions were held with the participation of world leading experts, including Nobel Laureates, and with attendees from over 60 countries. The upcoming congress will build on the success of previous events, with a focus on providing access to cutting-edge treatment and moving forward From Guidelines to Implementation.

OBESITY STIGMA CONFERENCE

Major scientific organizations team up for a Joint Consensus Conference on Obesity Stigma at WCITD 2019 on April 10. People with obesity face not only increased risk of serious medical complications but also a pervasive, resilient form of social stigma. Weight bias undermines access to evidence-based treatments, misleads public health policies, confuses messages in popular media and compromises advances in research. Hence, tackling stigma is not only a matter of social justice but also a way to advance prevention and treatment of obesity and related diseases. A multidisciplinary group, including obesity researchers, clinicians, advocacy experts and other stakeholders will discuss the gap between scientific evidence and the myths and misconceptions that reinforce stigma.

Participate in this unprecedented initiative to address a major stumbling block in the fight against the pandemic of obesity and diabetes!

ORGANIZING COMMITTEE

Francesco Rubino

Congress Director
King's College London

UK

Philip R. Schauer

Program Co-Chair
Cleveland Clinic

USA

David E. Cummings

Program Co-Chair
University of Washington

USA

Lee Kaplan

Program Co-Chair
Massachusetts General Hospital

USA

William Cefalu

Program Co-Chair
American Diabetes Association

USA

FACULTY

Meet our experienced and multidisciplinary faculty committed to making meaningful changes for
the future of diabetes

George Alberti Imperial College United Kingdom Stephanie Amiel King's College London United Kingdom David Arterburn Washington Health Institute USA Rachel Batterham University College London United Kingdom Hans-Rudolf Berthoud Pennington Biomedical Center USA Diego Bohorquez Duke University USA Ricardo Cohen Brazil Anita Courcoulas USA Robert Eckel Professor of Medicine USA Michel Gagner Hopital du Sacre Coeur Canada Manoel Galvao Neto Herbert Wertheim College USA George Alberti Belgium David Hopkins USA Jens Juul Holst University of Copenhagen Denmark Blandine Laferrere Columbia University USA Carel le Roux University College Dublin Ireland Jeffrey Mechanick Icahn School of Medicine USA John Morton USA Joe Nadglowski Obesity Action Coalition USA Mary Elizabeth Patti Joslin Diabetes Center USA Jaime Ponce CHI Memorial Hospital USA Walter Pories East Carolina University USA Harith Rajagopalan Co-founder & CEO
Fractyl Laboratories
USA
Caroline Rudisill University of South Carolina USA Donna Ryan Pennington Biomedical USA Bob Ryder Consultant Diabetologist United Kingdom Carlos Schiavon BP Hospital Brazil Randy Seeley University of Michigan USA Nicholas Stylopoulos Boston Children's Hospital USA Antonio Torres Universidad Complutense Spain Valentina Tremaroli University of Gothenburg Sweden

ENDORSED BY:

Slide Slide Slide Slide Slide Slide Slide Slide Slide Slide

KEY DATES

Regular Registration Deadline March 26, 2019
The Congress April 8 - 10, 2019

BEST PLACES TO STAY IN NEW YORK

We have hand-picked the best places to stay with special offers for participants

Follow #WCITD19

Subscribe to our newsletter

Subscribe to our newsletter and get the latest scientific updates and congress news